-
Psychometric Validation of the Modified Low Luminance Questionnaire in Patients With X-Linked Retinitis Pigmentosa
Mar 10, 2025, 14:00 PM -
Evaluating Imaging Artificial Intelligence (AI) Matching Real-World Digital Twins (rwDTs) Into an External Control Arm (ECA) for MYSTIC: A Phase 3 Clinical Trial in Metastatic Non-Small Cell Lung Cancer (mNSCLC)
Mar 10, 2025, 14:00 PM -
Estimation of Drug Cost Reductions by Introducing formularies for An Employment-based Health Insurance Plan : A Simulation Using “Wellness-Star☆” Health Insurance Claims Database
Mar 10, 2025, 14:00 PM -
Study on the Impact of the National Drug Price Negotiation Policy on the Affordability of Innovative Drugs in China
Mar 10, 2025, 14:00 PM -
Disease and Economic Burden of Dengue in Colombia, 2018-2022
Mar 10, 2025, 14:00 PM -
Epidemiological Analysis and Patient Profile of Lung Cancer in the Brazilian Public Health System: A Real-World Data Study
Mar 10, 2025, 14:00 PM -
Landscape of Patient-Reported Outcomes Measures (PROMs) in Oncology Trials: Key Insights Into Patient Voice and Value
Mar 10, 2025, 14:00 PM -
Systematic Evaluation of Bone Health Dynamics Associated With GLP-1 Receptor Agonists in Type 2 Diabetes Patients: Fracture Risk and Osteoporotic Complications
Mar 10, 2025, 14:00 PM -
The Institute for Clinical and Economic Review and Joint Clinical Assessment: Insights for Manufacturers in an Evolving Health Technology Assessment Landscape
Mar 10, 2025, 14:00 PM -
Key Clinical Drivers of the Long-Term Cost-Effectiveness of Semaglutide1mg for the Treatment of People With Type 2 Diabetes and Cronic Kidney Disease Based on the FLOW Clinical Trial
Mar 10, 2025, 14:00 PM -
Validity of Diagnostic Codes to Identify Metastatic Prostate Cancer in Medicare Claims Database
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Rosuvastatin and Ezetimibe Single Pill Combination (SPC) Versus Free Combination Treatment (FCT) in Chinese Hypercholesterolemia Adult Patients
Mar 10, 2025, 14:00 PM -
A New Device for Early Detection of Breast Disease: Stakeholders Perspective Analysis in Brazil/LATAM/LMIC
Mar 10, 2025, 14:00 PM -
Double Immune Checkpoint Inhibition as First-Line Treatment for BRAF-Mutant Advanced Melanoma: A Cost-Effectiveness Analysis from the Brazilian Private Healthcare System Perspective
Mar 10, 2025, 14:00 PM -
Real-World Healthcare Resource Utilization and Costs Associated with Elranatamab Initiation in Multiple Myeloma: the ALTITUDE-1 Study
Mar 10, 2025, 14:00 PM -
Dynamic Population Modelling Indicates a Flavored EVP Ban in the UK May Negatively Impact Population Health
Mar 10, 2025, 14:00 PM -
Framework for Real-World Data Used in Regulatory Submissions
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Tumor-Treating Fields in Combination With Temozolomide for Glioblastoma Patients: An Italian Healthcare System Perspective
Mar 10, 2025, 14:00 PM -
Horizon Scanning for Paroxysmal Nocturnal Hemoglobinuria in Brazil: Insights on Past Trends and Future Prospects
Mar 10, 2025, 14:00 PM -
Long-term Predictions for Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer: 40-year Period Extrapolation
Mar 10, 2025, 14:00 PM
